See every side of every news story
Published loading...Updated

Olpasiran significantly lowers "bad cholesterol" linked to cardiovascular risk

Summary by News Medical
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai researcher of a phase 2 trial.

4 Articles

All
Left
Center
1
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Wednesday, February 12, 2025.
Sources are mostly out of (0)